Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
VIENNA, Austria, July 14 /PRNewswire-FirstCall/ -- Elan Corporation, plc (NYSE: ELN ) and Wyeth (NYSE: WYE ) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) from seven posters and one podium presentation ab...
New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More
NEEDHAM, Mass., May 5 /PRNewswire/ -- A new Hospital Energy Performance Service can help hospitals to improve both building systems performance and energy efficiency by 25% or more -- with much of the savings linked to low-cost modifications. The service is available from Environmen...
Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions
The Hemobag(R) prevents wastage by saving the patient's own whole blood
SOMERS, Conn., May 6 /PRNewswire/ -- A recent paper in a journal for
perfusionists, the health professionals who manage patients on heart and
lung bypass machines during open heart surgery, reports how Global Blood
Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
RICHMOND, VA, January 29 /PRNewswire/ -- The American Magazine has just
released a Podcast interview with Insmed Therapeutic Proteins President
Steve Glover on how a generic, or follow-on biologics, industry is good fo...
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
- Completes Restructuring and Two Divestitures of Non-Core Product Lines -
HOPKINTON, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today reported third quarter financial
results for 2008 and the completion of two product line divestitures: the
sale of it...
Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
Physician Practices Encouraged to Apply for Incentive Program
RALEIGH, N.C., Aug. 16 /PRNewswire/ -- Beginning in 2008, physicians in
and around the Research Triangle Area (RTA) who provide top-quality care
will receive compensation for quality thanks to the RTA Health Care
Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004
U.S. health care cost increases continued to escalate at a double-digit pace in 2003, but there are indications that rate hikes may begin moderating as early as next year, according to global HR outsourcing and consulting firm Hewitt Associates (NYSE: HEW). For 2004, Hewitt is projecting a 12.6 per...
Cedara acquisition costs hit Merge Technologies numbers
MILWAUKEE - Merge Technologies, Inc. , a developer and provider of medical imaging and information management software and services, announced its second quarter results Tuesday morning, showing both growth and losses.
Although quarterly revenue was at a record high of $18.8 million, the comp...
Consultant says beware hidden costs of bad IT projects
Milwaukee, Wis. Hidden factors may contribute as much to the high failure rate of information technology projects as the easily identifiable suspects, technology executives were told Wednesday.
Robert Balon, a principal in Clerestory Consulting in Chicago, delivered that sobering message We...
DHC 2007: Without fuller IT adoption, health costs might drain America's wealth
Madison, Wis. - If the pace of healthcare information technology adoption doesn't pick up soon, the United States could reach an unsustainable situation regarding healthcare costs, according to John Wade, who delivered the keynote address Wednesday at Digital Healthcare Conference 2007 .
DHC 2007: Controlling health IT costs the key to capturing value
Madison, Wis. - Peter Strombom, the retired CIO of Meriter Hospital , believes healthcare might be the only industry where competition increases costs.
Why that distortion exists could be the subject of an entire conference, and it occupied a fair amount of time during Digital Healthcare C...
Fiserv Launches Avidyn Health to Target Healthcare Costs
Brookfield, Wis. - Fiserv Health, an operating group of Fiserv, Inc. has announced the launch of Avidyn Health, a care management company targeting the self-funded health care market.
Fiserv Health provides independent health plan management, claims processing and administration services fo...
Doubling the lily pads: Controlling the explosion in health care costs
MADISON Back in his math teacher days, Al Jacobs taught students about the power of doubling by talking about lily pads. Imagine a colony of lily pads on a pond and the pads doubled in area every day: How long would it take for an area of two square feet of lily pads to cover a pond of 250,000 squ...
Fiserv Health and Aetna help employers control health care costs
WAUSAU, Wis. Fiserv Health announced Wednesday it has entered into an agreement with Aetna Signature Administrators to gain access to Aetna's PPO network and stop-loss services for the clients of Wausau Benefits , a Fiserv Health company. This initiative is directed at self-funded employers wi...
Super advertising slogans, and super costs
Advertising slogans or taglines pushing sales are great for getting a customers attention as they often tangle and hold them hostage for a second or two.
Some taglines catch the users attention, but most are simply confusing, causing them to escape the trap and run away.
The combined yearly...
Wi-Fi flows freely, but it costs
First, the good news: wireless connectivity truly is moving quickly to ubiquity. Traveling across Europe these past two weeks, my daily dose of broadband has been, exclusively, a Wi-Fi connection. I'd venture to say that hotels throughout Europe are more likely to offer broadband wireless than ...
Manufacturers concerned with rising material costs
Madison, Wis. - Most Wisconsin manufacturers polled in a recent survey say that concerns about rising raw materials costs
and pricing pressures outweigh anxiety about offshore competition.
The Wisconsin Manufacturing Extension Partnership , a nonprofit consulting organization for small and mi...
Novavax Reports Second Quarter 2009 Financial Results
...ntracts in 2009.
Research and development costs
were $5.3 million for the second quarter of 2009 c...fset by a $0.1 million increase in outside testing costs
associated with continuing clinical trials, precli...ated programs.
General and administrative costs
were $2.6 million in the second quarter of 2009 as...
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
... $- $- $- $-
development 1,376,253... ------- ------- -------
expenses 1,768,812 2,463,677 4,813,355 4,18...
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
...13.2 million, compared to $13.9 million in the prior year's period.
Excluding $1.4 million of interest expense and $0.2 million of amortized
related to the Company's outstanding convertible notes, the
Company's net income attributable to controlling interest increased 6.5% to
AutoImmune Inc. Reports 2009 Second Quarter Financial Results
... -------- -------- -------- --------
Cost of goods sold 16,000 50,000 28... ------- ------- ------- -------
expenses 245,000 260,000 504,000 5...
Synthetech Reports First Quarter Fiscal 2010 Results
...production difficulties in prior quarters; higher than average raw material costs
on certain projects; and low margins on material purchased for direct resel...pay. As a result of these changes, Synthetech incurred $53,000 of severance costs
in the first quarter of fiscal 2010.
Synthetech's cash and cash eq...
GenVec Reports Second Quarter 2009 Financial Results
...te, lab, data management, monitoring and materials costs
related to our TNFerade(TM) program, reduced materials costs
related to our funded programs, and reduced genera... periods by increases related to the manufacturing costs
of TNFerade arising from the letter agreement and ...
ThermoGenesis Provides Update on Fiscal 2009 Results
...ng to the fourth quarter results are non-recurring costs
of approximately $1.6 million, including non-cash ...ges primarily include $0.3 million in reserves for costs
related to a transition to an upgraded AXP devic...duct line.
Also included in non-recurring costs
in the fourth quarter are several cash charges t...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... approximately 20 percent, primarily attributed to costs
related to preparation for the anticipated commerc...the first six months of 2008, primarily reflecting costs
related to preparation for the anticipated commerc... 7,928 8,114 14,778 17,428
Cost of goods sold ...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...es force which began in February 2009.
and expenses for the second quarter of 2009 were $... 57% for the first six months of 2008.
and expenses for the first six months of 2009 were...9,168 12,845 17,856 23,420
OncoGenex Reports Second Quarter 2009 Financial Results
...reases in 2009 were primarily due to manufacturing costs
incurred in the first six months of 2009 associate... increase in employee expenses and higher facility costs
resulting from the reverse takeover of Sonus. Redu...y due to increased employee expenses and increased costs
associated with operating as a public company.
Telik Announces Second Quarter 2009 Financial Results
...r the quarter ended June 30, 2009, total operating costs
and expenses were $6.3 million, compared with $11.... ---- ---- ---- ----
Research and development ... 2,773 6,086 5,186
83 - 951 -
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
Hsp90 inhibitor candidate.
Under the terms of the agreement, Debiopharm will assume all future
development responsibility and incur all future costs
related to the licensed
Hsp90 technology, including CUDC-305. Curis currently expects that Debiopharm
will file an application with health authorities...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
...ensation expenses and other non-
were $6.1 million.
- Selling, general and a...ng financing fees and other non-
were $19.0 million.
- GAAP net loss and net... due to licensors and excludes amounts accrued for costs
incurred. Adjusted net income (loss), adjusted net...
Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval
..., competitive factors, technological developments, costs
of developing, producing and selling OPAXIO, pixan...zation of
debt discount and
(497) (30,202) (5,348) (41,146)... Write-off of
- (2,361) - (2,361)
PDI Reports 2009 Second Quarter Financial Results
"In addition, we continue to manage costs
and have consolidated office space in our marketin...the impact of $1.8 million of facility realignment costs
related to excess office space in the Company's Ma...business in 2009 and the impact of $0.7 million in costs
associated with the retirement of our former Chief...
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... a maximum of $390 million, and will also pay tiered, double-digit royalties on net sales of the products. Shire also reimburses worldwide development costs
on a 50/50 basis, and in return Shire received rights to commercialize these products outside of the U.S. while Amicus retains all rights to commercia...
Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
...on reported for the comparable period in 2008. The decreases in the current year expenses are primarily due to a reduction in research and development costs
as the company completed its clinical development program for Acetavance in early 2009 and submitted an NDA for this product candidate in May 2009. Fu...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
...f METAZYM(R) from
Zymenex A/S ($135.0 million) and costs
associated with the cessation of
Write down of inventory and
for DYNEPO - (53.4)
... - (90.4)
New holding company costs
The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.
...liplatin injection (Eloxatin(R)) and enoxaparin sodium injection (Lovenox(R)) - will be made over the course of one year.
"At a time when the costs
of managing clinical trials are on the rise and budgets are extremely tight, receiving pharmaceutical products at no cost enables us to extend the Cen...
Plastics that convert light to electricity could have a big impact
...r likely to reach the 10 percent efficiency threshold.
Making solar cells more efficient is crucial to making them cost effective, he said. And if costs
can be brought low enough, solar cells could offset the need for more coal-generated electricity in years to come.
"The solution to the energy pro...
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
...th the regulation of our tests by FDA; our ability to compete against third parties; our ability to develop and commercialize new tests; unanticipated costs
or delays in research and development efforts; our ability to obtain capital when needed; our history of operating losses; the results of clinical stu...
Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
...neral economic conditions, the retention of hematology OEM and proficiency survey business, the impact of currency exchange rate fluctuations, and the costs
and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed ...
ETC Biomedical Announces Chamber Sale in India
...ficant shareholder, and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs
of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items ...